This generic
clearance for FDA customer service surveys is approved consistent
with the revised supporting statement of (5/25/05) under the
following conditions: 1) FDA shall use the generic clearance only
for customer satisfaction and web site user surveys where FDA seeks
to gather information for general service improvement, not for
publication or for the purpose of informing significant policy or
resource allocation decisions. 2) FDA shall submit an 83-C along
with an abbreviated supporting statement for individual surveys
(e.g., statement of need, intended use of information, description
of respondents, information collection procedures, expected
response rate, justification for incentive, estimated burden). 3)
OMB will respond with clearance or questions within 10 working
days.
Inventory as of this Action
Requested
Previously Approved
05/31/2008
05/31/2008
05/31/2008
6,000
0
6,000
1,800
0
1,800
0
0
0
This agreeement will allow FDA to
conduct customer satisfaction surveys to gain important feedback
from regulated entities such as food processors, cosmetic, drug,
biologic, and medical device manufacturers as well as consumers and
health professionals and partner surveys of the State and local
governments.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Customer/Partner Service Surveys - (Extension)